Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

US10308591B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10308591-B2
Application numberUS-201815874747-A
CountryUS
Kind codeB2
Filing dateJan 18, 2018
Priority dateAug 10, 2006
Publication dateJun 4, 2019
Grant dateJun 4, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure concerns the discovery of (R,R)- and (R,S)-fenoterol analogs which are highly effective at binding β2-adrenergic receptors. Exemplary chemical structures for these analogs are provided. Also provided are pharmaceutical compositions including the disclosed (R,R)-fenoterol and fenoterol analogs, and methods of using such compounds and compositions for the treatment of cardiac disorders such as congestive heart failure and pulmonary disorders such as asthma or chronic obstructive pulmonary disease.

First claim

Opening claim text (preview).

We claim: 1. A method for treating congestive heart failure in a subject, comprising: administering to the subject with the cardiovascular disorder a therapeutically effective amount of a compound having the formula 2. The method of claim 1 , wherein the compound is 3. The method of claim 1 , wherein administering a therapeutically effective amount of the compound comprises administering a pharmaceutical composition comprising the therapeutically effective amount of the compound and at least one pharmaceutically acceptable carrier. 4. The method of claim 1 , wherein administering the therapeutically effective amount of the compound to the subject increases cardiomyocyte contractility.

Assignees

Inventors

Classifications

  • Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure · CPC title

  • Drugs for disorders of the cardiovascular system · CPC title

  • for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title

  • Antiasthmatics · CPC title

  • Drugs for disorders of the respiratory system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10308591B2 cover?
This disclosure concerns the discovery of (R,R)- and (R,S)-fenoterol analogs which are highly effective at binding β2-adrenergic receptors. Exemplary chemical structures for these analogs are provided. Also provided are pharmaceutical compositions including the disclosed (R,R)-fenoterol and fenoterol analogs, and methods of using such compounds and compositions for the treatment of cardiac diso…
Who is the assignee on this patent?
Us Health
What technology area does this patent fall under?
Primary CPC classification C07C215/60. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).